Final Conference of PROGRESS in conjunction with the European Biotechnology Week took place
Wednesday September 27th, 2017 from 9:30 am to 04:30 pm
at the Hotel Crowne Plaza Brussels - Le Palace
(Rue Gineste 3, 1210 Brussels, Belgium).
Please find the detailed agenda attached.
Presentations from Fraunhofer ISI:
Presentations from external Speakers:
The workshop aims at elaborating goals for R&DI policy in Industrial Biotechnology in Europe.
The workshop will take place in Brussels
Thursday May 18th, 2017 from 10:00 am to 05:00 pm
at the European Commission Covent Garden (COVE) Place Rogier 16, Brussels.
The following steps will be taken in the workshop:
Key policy-relevant factors for the future development of Industrial Biotechnology will be presented and discussed and modified. For these factors, potential goals for Europe in 2025-2030 will be elaborated by taking into account potential uncertainties and conflicts as well as perspectives of other stakeholders. On this basis actions will be deduced. The goals and actions will be illustrated for certain value chains (bio-based plastics, enzymes, biotech flavors & fragrances) as examples.
The workshop will require your active participation in moderated group discussions. You will have the opportunity to ex-change views with about around 15-20 leading experts from academia and industry and to contribute to setting the course for research and innovation policy in the coming years. The results of the workshop will be used to prioritize R&D&I needs and propose potential actions in later stages of the project.
If you are interested, please contact us until the 18.April 2017. Request for travel reimbursement is possible.
The value chain workshops were key activities of
the project. Each workshop covered two value chains, which present key
opportunities for Europe, but
also are representative to analyze gaps and further needs of action. The
following workshops took place
All workshops will take place in a location
nearby the Frankfurt/Main airport in Germany.
In these workshops scenarios of future pathways for Industrial Biotechnology (IB) were elaborated by the participants. The future paths scenarios cover the relevant aspects that have to be addressed to enter those paths, such as technological bottlenecks, market barriers or framework conditions.
Representatives from the scientific communities, from industry, associations, consultancies and policy-making were invited to share their experience and expertise about the prospective IB developments and related impacts in Europe. The different stakeholders groups will reflect together on the vision they have about the future of technology, economy and society for these value chains.